Mark Bachleda - 08 Oct 2021 Form 3 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role: Chief Commercial Officer
Signature: /s/ J. Mel Sorensen, Attorney-in-Fact for Mark J. Bachleda
Issuer symbol: GRTX
Transactions as of: 08 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 12 Oct 2021, 20:18:56 UTC
Next filing: 02 Mar 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney